Taxis Pharmaceuticals Inc

Overview

Your Content Goes Here Learn More Antimicrobial resistance is projected to kill up to 10 million people a year by 2050. We won’t let this happen. TAXIS Pharmaceuticals is developing investigational therapies to combat antimicrobial resistance – we're addressing the root causes of the issue and targeting the very foundation of

Classification

This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.

1. Manufacturing32
2. Chemical Manufacturing325
3. Pharmaceutical and Medicine Manufacturing32541
4. Pharmaceutical Preparation Manufacturing325412